Subscribe To
Manganese x energy completes final processing metallurgical phase for battery hill pea, highlighted by novel purification process
Manganese X Energy Corp (TSX-V:MN, OTCQB:MNXXF) has wrapped up the third and final processing metallurgical phase for the upcoming preliminary economi...
February 1, 2022, 9:21 am
Thermo fisher (tmo) base sales rebound, bioproduction in focus
Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used...
January 27, 2022, 1:04 pm
Thermo fisher (tmo) base sales rebound, bioproduction in focus
Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used...
January 27, 2022, 1:04 pm
Thermo fisher (tmo) base sales rebound, bioproduction in focus
Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used...
January 27, 2022, 1:04 pm
Cabot: a few interesting developments
CBT's decision to sell its purification Solutions division should be taken well. CBT's Investor Day to ...
November 29, 2021, 1:06 pm
Cabot: a few interesting developments
CBT's decision to sell its purification Solutions division should be taken well. CBT's Investor Day to ...
November 29, 2021, 1:06 pm
Cabot: a few interesting developments
CBT's decision to sell its purification Solutions division should be taken well. CBT's Investor Day to ...
November 29, 2021, 1:06 pm
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm